These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 19212427)
1. Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer. Hedman M; Muona K; Hedman A; Kivelä A; Syvänne M; Eränen J; Rantala A; Stjernvall J; Nieminen MS; Hartikainen J; Ylä-Herttuala S Gene Ther; 2009 May; 16(5):629-34. PubMed ID: 19212427 [TBL] [Abstract][Full Text] [Related]
2. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Hedman M; Hartikainen J; Syvänne M; Stjernvall J; Hedman A; Kivelä A; Vanninen E; Mussalo H; Kauppila E; Simula S; Närvänen O; Rantala A; Peuhkurinen K; Nieminen MS; Laakso M; Ylä-Herttuala S Circulation; 2003 Jun; 107(21):2677-83. PubMed ID: 12742981 [TBL] [Abstract][Full Text] [Related]
3. Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state. Schalch P; Rahman GF; Patejunas G; Goldschmidt RA; Carbray J; Retuerto MA; Kim D; Esser K; Crystal RG; Rosengart TK J Thorac Cardiovasc Surg; 2004 Feb; 127(2):535-40. PubMed ID: 14762365 [TBL] [Abstract][Full Text] [Related]
4. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Rajagopalan S; Mohler ER; Lederman RJ; Mendelsohn FO; Saucedo JF; Goldman CK; Blebea J; Macko J; Kessler PD; Rasmussen HS; Annex BH Circulation; 2003 Oct; 108(16):1933-8. PubMed ID: 14504183 [TBL] [Abstract][Full Text] [Related]
5. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome. Chyrchel M; Rakowski T; Rzeszutko L; Legutko J; Dziewierz A; Dubiel JS; Dudek D Kardiol Pol; 2006 Dec; 64(12):1357-62; discussion 1363. PubMed ID: 17206539 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients. Han YL; Wang SL; Jin QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G Chin Med J (Engl); 2006 Apr; 119(7):544-50. PubMed ID: 16620694 [TBL] [Abstract][Full Text] [Related]
7. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry). Feldman DN; Gade CL; Slotwiner AJ; Parikh M; Bergman G; Wong SC; Minutello RM; Am J Cardiol; 2006 Nov; 98(10):1334-9. PubMed ID: 17134624 [TBL] [Abstract][Full Text] [Related]
8. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF Chin Med J (Engl); 2008 Mar; 121(6):485-91. PubMed ID: 18364130 [TBL] [Abstract][Full Text] [Related]
9. Fluvastatin reduces the impact of diabetes on long-term outcome after coronary intervention--a Lescol Intervention Prevention Study (LIPS) substudy. Arampatzis CA; Goedhart D; Serruys PW; Saia F; Lemos PA; de Feyter P; Am Heart J; 2005 Feb; 149(2):329-35. PubMed ID: 15846273 [TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent. Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of percutaneous coronary interventions in patients with non ST segment elevation acute coronary syndrome in catheterisation laboratory without on-site surgical back-up. Dudek D; Rakowski T; Legutko J; Mielecki W; Dziewierz A; Bartuś S; Rzeszutko Ł; Sadowski J; Zmudka K; Dubiel JS Kardiol Pol; 2003 May; 58(5):356-65; discussion: 365. PubMed ID: 14523483 [TBL] [Abstract][Full Text] [Related]
12. Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial. Rajagopalan S; Mohler E; Lederman RJ; Saucedo J; Mendelsohn FO; Olin J; Blebea J; Goldman C; Trachtenberg JD; Pressler M; Rasmussen H; Annex BH; Hirsch AT; Am Heart J; 2003 Jun; 145(6):1114-8. PubMed ID: 12796772 [TBL] [Abstract][Full Text] [Related]
13. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Rutanen J; Rissanen TT; Markkanen JE; Gruchala M; Silvennoinen P; Kivelä A; Hedman A; Hedman M; Heikura T; Ordén MR; Stacker SA; Achen MG; Hartikainen J; Ylä-Herttuala S Circulation; 2004 Mar; 109(8):1029-35. PubMed ID: 14967735 [TBL] [Abstract][Full Text] [Related]
14. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. Ijsselmuiden AJ; Ezechiels J; Westendorp IC; Tijssen JG; Kiemeneij F; Slagboom T; van der Wieken R; Tangelder G; Serruys PW; Laarman G Am Heart J; 2004 Sep; 148(3):467-74. PubMed ID: 15389234 [TBL] [Abstract][Full Text] [Related]
15. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions. Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316 [TBL] [Abstract][Full Text] [Related]
16. [Long-term follow-up of patients treated with intracoronary thrombolysis or percutaneous transluminal coronary angioplasty for acute myocardial infarction]. Mori T; Nosaka H; Kimura T; Nobuyoshi M J Cardiol; 1991; 21(2):323-36. PubMed ID: 1841920 [TBL] [Abstract][Full Text] [Related]
18. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. Hueb WA; Bellotti G; de Oliveira SA; Arie S; de Albuquerque CP; Jatene AD; Pileggi F J Am Coll Cardiol; 1995 Dec; 26(7):1600-5. PubMed ID: 7594092 [TBL] [Abstract][Full Text] [Related]
19. Primary coronary angioplasty in patients with ST segment elevation acute myocardial infarction and diabetes. Dudek D; Mielecki W; Wizimirski M; Rakowski T; Dziewierz A; Sorysz D; Tomala M; Zorkun C; Zmudka K; Dubiel JS Kardiol Pol; 2004 Sep; 61(9):232-41; discussion 242. PubMed ID: 15531935 [TBL] [Abstract][Full Text] [Related]
20. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). Rodriguez AE; Baldi J; Fernández Pereira C; Navia J; Rodriguez Alemparte M; Delacasa A; Vigo F; Vogel D; O'Neill W; Palacios IF; J Am Coll Cardiol; 2005 Aug; 46(4):582-8. PubMed ID: 16098419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]